Johnson & Johnson to pay $2.2 billion for making false marketing claims and engaging in kickbacks

Natural News 6 Nov 2013

In what’s considered one of the country’s largest health care fraud settlements  and one of the largest whistleblower payouts in U.S. history, Johnson &  Johnson will pay $2.2 billion to settle charges involving the company’s role in  marketing three prescription drugs for unapproved uses. As the saying goes, “But  wait. There’s more.”

Johnson & Johnson, along with two subsidiaries,  Janssen Pharmaceuticals and Scios, also paid kickbacks to doctors and nursing  homes who touted their drugs, created “ElderCare Sales Forces” who were paid to  push the drug and sent pharmacists to hospitals to assess patient records.

Read more…

Leave a Reply

Your email address will not be published. Required fields are marked *